Source: Reuters The U.S. Food and Drug Administration on Wednesday said it approved Pfizer Inc's (PFE.N) ointment to treat mild…...

Source: PR Newswire Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced that William…...

Source: Aclaris Therapeutics' investigational new drug (IND) application for ATI-50001, an orally administered investigational Janus Kinase (JAK) inhibitor, for the…...

Source: Globe Newswire Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced top-line results from the Company’s Phase 2 clinical…...

Source: Novartis’ Cosentyx and Celgene’s Otezla aren’t just battling it out in the psoriasis arena. As of early this year,…...

Source: The Wall Street Journal Valeant Pharmaceuticals International Inc. cut its annual outlook again Tuesday as the drug company, struggling…...

Source: LinkedIn Thank you to our Elite Talent Network!! QFR Solutions has earned the Top spot (#1) in LinkedIn’s Top…...

Source: FierceBiotech Biotech IPOs are faring well this fall. That’s despite tough talk from U.S. politicians on biopharma pricing, as…...

Source: Allergan, which made its name with dermatology products like Botox, recalled more than 42,000 tubes of an acne gel…...

Source: Business Wire Encore Dermatology, Inc., a leader in developing and commercializing novel, prescription products for improving skin health, today…...